当前位置:首页 - 行情中心 - 蔚蓝生物(603739) - 财务分析

蔚蓝生物

(603739)

  

流通市值:39.35亿  总市值:39.35亿
流通股本:2.53亿   总股本:2.53亿

蔚蓝生物(603739)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.25亿元,每股收益0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益192611.21万元,未分配利润79824.12万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产307613.60万元,负债115002.39万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入345,050,139.431,366,123,678.631,015,793,037.32652,193,328.83
营业总成本319,210,567.091,281,214,678.35946,888,887.21611,538,303.12
其他经营收益
营业利润32,229,451.22127,591,514.41109,555,137.253,948,145.24
利润总额32,230,638.1123,705,917.89108,383,832.3153,074,950.17
净利润25,451,987.0497,465,510.6582,929,836.0839,804,417.47
每股收益
其他综合收益-480,627.11224,554.39-219,343.11-166,749.78
综合收益总额24,971,359.9397,690,065.0482,710,492.9739,637,667.69
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,237,984,214.111,178,619,183.051,149,287,280.251,037,784,862.72
非流动资产:
非流动资产合计1,838,151,794.921,861,040,116.271,892,244,394.661,911,035,043.21
资产总计3,076,136,009.033,039,659,299.323,041,531,674.912,948,819,905.93
流动负债:
流动负债合计1,040,557,660.11,007,084,872.411,063,345,832.141,017,099,430.62
非流动负债:
非流动负债合计109,466,269.3121,854,811.8976,983,738.8272,889,396.61
负债合计1,150,023,929.411,128,939,684.31,140,329,570.961,089,988,827.23
所有者权益(或股东权益):
归属于母公司股东权益合计1,799,752,986.631,782,521,319.491,774,027,009.241,738,999,631.54
股东权益合计1,926,112,079.621,910,719,615.021,901,202,103.951,858,831,078.7
负债和股东权益合计3,076,136,009.033,039,659,299.323,041,531,674.912,948,819,905.93
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计405,531,124.491,440,086,388.671,088,277,035.44734,257,983.1
经营活动现金流出小计387,268,536.21,326,138,907.281,054,520,263.63724,132,351.57
经营活动产生的现金流量净额18,262,588.29113,947,481.3933,756,771.8110,125,631.53
投资活动产生的现金流量:
投资活动现金流入小计76,673,189.59925,038,804.92679,521,360.27563,439,741.16
投资活动现金流出小计114,965,272.91999,633,710.05721,034,075.45556,982,488.18
投资活动产生的现金流量净额-38,292,083.32-74,594,905.13-41,512,715.186,457,252.98
筹资活动产生的现金流量:
筹资活动现金流入小计136,660,015.22754,723,029.39530,553,730.79366,467,913.25
筹资活动现金流出小计134,189,861.55792,185,784.78560,203,638.7438,288,337.1
筹资活动产生的现金流量净额2,470,153.67-37,462,755.39-29,649,907.91-71,820,423.85
汇率变动对现金及现金等价物的影响--177,201.94--
现金及现金等价物净增加额-17,559,341.361,712,618.93-37,405,851.28-55,237,539.34
期末现金及现金等价物余额217,479,735.89235,039,077.25195,920,607.04178,088,918.98
补充资料:
现金及现金等价物的净增加额-1,712,618.93--55,237,539.34
最新报告期:2026-05-08
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
国信证券李瑞楠,江海航,鲁家瑞0.380.400.402026-05-08
中信证券刘易,王涛,田鹏,王子昂,白弘伟0.320.340.372026-05-07
西南证券徐卿0.320.350.472026-04-27
TOP↑